NDC 30798-971 - Ivermectin Cattle Pour-On
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 30798-971
- Package NDCs from labels
- 30798-971-73
- Manufacturer
- Durvet, Inc.
- Effective date
- 2026-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ivermectin Cattle Pour-On - Durvet, Inc. | Durvet, Inc. | 2026-04-09 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 30798-971-73 | Ivermectin Cattle Pour-On | 4000 mL in 1 BOTTLE | SOLUTION | 4000 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOOLANTRA | IVERMECTIN | Galderma Laboratories, L.P. | b1d5b166-ab06-4ab5-b0c6-31126238118a | 2024-10-24 | Adverse reactions | 8883YP2R6D |
| STROMECTOL | IVERMECTIN | Merck Sharp & Dohme LLC | 681888c9-af79-4b7d-ae80-c3f4f6f1effd | 2024-09-20 | Warnings, Adverse reactions | 8883YP2R6D |
| ivermectin | IVERMECTIN | EPIC PHARMA LLC | c8005642-3bf0-41b9-8a53-8b933c68c073 | 2024-08-28 | Warnings, Adverse reactions | 8883YP2R6D |
| Ivermectin | IVERMECTIN | Rite Aid Corporation | 3a2eb7f3-b72b-435c-a609-ce7050cccff4 | 2024-08-12 | Warnings | 8883YP2R6D |
| Ivermectin | IVERMECTIN | NuCare Pharmaceuticals,Inc. | ad6539f2-94de-1bc5-e053-2a95a90a4cf2 | 2024-07-17 | Warnings, Adverse reactions | 8883YP2R6D |
| Sklice | IVERMECTIN | Azurity Pharmaceuticals | 7579bdfe-a538-4bff-b7c7-df2c4b6f13db | 2024-07-11 | Warnings | 8883YP2R6D |
| Ivermectin | IVERMECTIN | Bryant Ranch Prepack | 75973e89-a03f-48dd-8fe8-8eafc1938d09 | 2024-04-30 | Adverse reactions | 8883YP2R6D |
| Ivermectin | IVERMECTIN | Padagis Israel Pharmaceuticals Ltd | 1d3e7aea-02a4-46b1-8a14-0324e4777cb4 | 2024-03-31 | Adverse reactions | 8883YP2R6D |
| ivermectin | IVERMECTIN | Viona Pharmaceuticals Inc | 6b4a7400-d34c-4947-90e6-340f7087a702 | 2024-03-27 | Adverse reactions | 8883YP2R6D |
| Ivermectin | IVERMECTIN | Bryant Ranch Prepack | 81193a2d-dc0a-4ce5-a5c1-6dfd3195c4bc | 2023-10-30 | Adverse reactions | 8883YP2R6D |
| Ivermectin | IVERMECTIN | Asclemed USA, Inc. | 014e33e7-c07d-4feb-a2cf-7cd160b1facd | 2023-10-05 | Warnings, Adverse reactions | 8883YP2R6D |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 9M64UO4C25 |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 9M64UO4C25 |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 9M64UO4C25 |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | 9M64UO4C25 |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | 9M64UO4C25 |
| IVERMECTIN | IVERMECTIN | Mayne Pharma Inc. | 39fbf2b3-cd2f-4e04-99c4-ca4390fae2bd | 2023-08-29 | Adverse reactions | 8883YP2R6D |
| ivermectin | IVERMECTIN | Zydus Lifesciences Limited | 22e85f9a-0805-47f2-8709-aa6514511b04 | 2023-06-07 | 8883YP2R6D | |
| Ivermectin | IVERMECTIN | Walgreen Company | b8e1d919-ba66-4dc0-b0fc-cfb3a229dad9 | 2022-01-04 | Warnings | 8883YP2R6D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.